Concepedia

Christopher G. Hallgren

CG

Statistics

Publications

2

Citations

336

H-Index

2

Active since

2001

Affiliations

Mayo Clinic in Arizona(Current)

Christopher G. Hallgren is an author at Mayo Clinic in Arizona specializing in glioma, oncology, and tumor biology.

Top concepts

Publications per year

2001–2002

2

Publications

2

The HER tyrosine kinase inhibitor CI1033 enhances cytotoxicity of 7-ethyl-10-hydroxycamptothecin and topotecan by inhibiting breast cancer resistance protein-mediated drug efflux.

Charles Erlichman, Scott A. Boerner, Christopher G. Hallgren et al. · PubMed · 2001 · 222 citations

, , +15

Effects of the Bcr/abl kinase inhibitors STI571 and adaphostin (NSC 680410) on chronic myelogenous leukemia cells in vitro

Benjamin Mow, Joya Chandra, Phyllis A. Svingen et al. · Blood · 2002 · 114 citations · Full text

1–2 of 2